BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18018502)

  • 1. [Patients also need to measure blood glucose in the postprandial period].
    Aumiller J
    MMW Fortschr Med; 2007 Oct; 149(40):17. PubMed ID: 18018502
    [No Abstract]   [Full Text] [Related]  

  • 2. [Specific effect of postprandial glycemic peaks on HBA1c and angiopathy].
    Avignon A; Monnier L
    Diabetes Metab; 2000 Jun; 26 Suppl 2():12-5. PubMed ID: 10975044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of post-prandial hyperglycemia and its implications.
    Shah SN; Das AK
    J Assoc Physicians India; 2001 Jan; 49 Spec No():1-2. PubMed ID: 11245155
    [No Abstract]   [Full Text] [Related]  

  • 4. [Monitoring post-prandial blood sugars in the diabetic patient].
    Boche S; Bouffard S
    Rev Infirm; 2010 Nov; (165):40-2. PubMed ID: 21121170
    [No Abstract]   [Full Text] [Related]  

  • 5. Discordance between HbA1c and glycemia.
    Misra A; Bloomgarden ZT
    J Diabetes; 2018 Dec; 10(12):908-910. PubMed ID: 30126041
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of postprandial glucose control on diabetes-related complications: How is the evidence evolving?
    Madsbad S
    J Diabetes Complications; 2016 Mar; 30(2):374-85. PubMed ID: 26541075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry.
    Karter AJ; Ackerson LM; Darbinian JA; D'Agostino RB; Ferrara A; Liu J; Selby JV
    Am J Med; 2001 Jul; 111(1):1-9. PubMed ID: 11448654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study.
    Borg R; Kuenen JC; Carstensen B; Zheng H; Nathan DM; Heine RJ; Nerup J; Borch-Johnsen K; Witte DR;
    Diabetes; 2010 Jul; 59(7):1585-90. PubMed ID: 20424232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postprandial blood glucose. American Diabetes Association.
    American Diabetes Association
    Diabetes Care; 2001 Apr; 24(4):775-8. PubMed ID: 11315848
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of self-monitoring of blood glucose during the treatment of type 2 diabetes with medications targeting postprandial hyperglycemia.
    Choe C; Edelman SV
    South Med J; 2007 Nov; 100(11):1123-31. PubMed ID: 17984745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Blood glucose self monitoring (Update 2019)].
    Wascher TC; Stechemesser L; Harreiter J;
    Wien Klin Wochenschr; 2019 May; 131(Suppl 1):115-118. PubMed ID: 30980155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular risk.
    Gerich JE; Odawara M; Terauchi Y
    Curr Med Res Opin; 2007 Aug; 23(8):1791-8. PubMed ID: 17610805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements.
    Dailey G
    Mayo Clin Proc; 2007 Feb; 82(2):229-35; quiz 236. PubMed ID: 17290732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalizing treatment in type 2 diabetes: a self-monitoring of blood glucose inclusive innovative approach.
    Ceriello A; Gallo M; Armentano V; Perriello G; Gentile S; De Micheli A;
    Diabetes Technol Ther; 2012 Apr; 14(4):373-8. PubMed ID: 22216963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: The role of glucagon in postprandial hyperglycemia--the jury's still out.
    Bollyky J; Greenbaum CJ
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2879-81. PubMed ID: 17682088
    [No Abstract]   [Full Text] [Related]  

  • 16. Postprandial and basal hyperglycaemia in type 2 diabetes: Contributions to overall glucose exposure and diabetic complications.
    Monnier L; Colette C
    Diabetes Metab; 2015 Dec; 41(6 Suppl 1):6S9-6S15. PubMed ID: 26774019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood glucose control in type 2 diabetes. Basic requirements for reducing vascular complications].
    Seissler J
    Internist (Berl); 2007 Jul; 48(7):676, 678-80, 682 passim. PubMed ID: 17541528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensified glucose control in type 2 diabetes--whose agenda?
    Yudkin JS; Richter B; Gale EA
    Lancet; 2011 Apr; 377(9773):1220-2. PubMed ID: 21093903
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications.
    Brownlee M; Hirsch IB
    JAMA; 2006 Apr; 295(14):1707-8. PubMed ID: 16609094
    [No Abstract]   [Full Text] [Related]  

  • 20. Contribution of fasting and postprandial hyperglycemia to hemoglobin A1c in insulin-treated Japanese diabetic patients.
    Shimizu H; Uehara Y; Okada S; Mori M
    Endocr J; 2008 Aug; 55(4):753-6. PubMed ID: 18497454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.